ZBH stock icon

Zimmer Biomet

109.94 USD
+0.48
0.44%
At close Nov 12, 4:00 PM EST
After hours
109.94
+0.00
0.00%
1 day
0.44%
5 days
-2.36%
1 month
4.87%
3 months
2.75%
6 months
-8.07%
Year to date
-9.43%
1 year
3.89%
5 years
-23.94%
10 years
-0.84%
 

About: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Employees: 18,000

0
Funds holding %
of 6,759 funds
0
Analysts bullish %
of 15 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% less funds holding

Funds holding: 993 [Q1] → 990 (-3) [Q2]

3% less first-time investments, than exits

New positions opened: 92 | Existing positions closed: 95

2.51% less ownership

Funds ownership: 94.04% [Q1] → 91.52% (-2.51%) [Q2]

11% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]

17% less capital invested

Capital invested by funds: $24.7B [Q1] → $20.4B (-$4.28B) [Q2]

25% less repeat investments, than reductions

Existing positions increased: 300 | Existing positions reduced: 399

38% less call options, than puts

Call options by funds: $45.4M | Put options by funds: $73.6M

Research analyst outlook

15 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$110
0%
upside
Avg. target
$119
8%
upside
High target
$135
23%
upside

15 analyst ratings

positive
33%
10 neutral
67%
negative
0%
RBC Capital
Shagun Singh
56% 1-year accuracy
44 / 78 met price target
14%upside
$125
Outperform
Maintained
4 Nov 2024
Truist Securities
Richard Newitter
72% 1-year accuracy
34 / 47 met price target
6%upside
$117
Hold
Maintained
1 Nov 2024
Wells Fargo
Larry Biegelsen
62% 1-year accuracy
26 / 42 met price target
6%upside
$117
Equal-Weight
Maintained
31 Oct 2024
Oppenheimer
Steven Lichtman
63% 1-year accuracy
12 / 19 met price target
23%upside
$135
Outperform
Maintained
15 Oct 2024
Raymond James
Jayson Bedford
63% 1-year accuracy
19 / 30 met price target
12%upside
$123
Outperform
Maintained
14 Oct 2024

Financial journalist opinion

Based on 14 articles about ZBH published over the past 30 days

Charts implemented using Lightweight Charts™